Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.4 (
deaminase
)
5,113
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Clostridium perfringens
is a bacterial pathogen that causes necrotic enteritis in poultry and livestock, and is a source of food poisoning and
gas gangrene
in humans. As the agriculture industry eliminates the use of antibiotics in animal feed, alternatives to antibiotics will be needed. Bacteriophage endolysins are enzymes used by the virus to burst their bacterial host, releasing bacteriophage particles. This type of enzyme represents a potential replacement for antibiotics controlling
C. perfringens
. As animal feed is often heat-treated during production of feed pellets, thermostable enzymes would be preferred for use in feed. To create thermostable endolysins that target
C. perfringens
, thermophile endolysin catalytic domains were fused to cell wall binding domains from different
C. perfringens
prophage endolysins. Three thermostable catalytic domains were used, two from prophage endolysins from two
Geobacillus
strains, and a third endolysin from the deep-sea thermophilic bacteriophage
Geobacillus
virus E2 (GVE2). These domains harbor predicted L-alanine-
amidase
, glucosaminidase, and L-alanine-
amidase
activities, respectively and degrade the peptidoglycan of the bacterial cell wall. The cell wall binding domains were from
C. perfringens
prophage endolysins (Phage LYtic enzymes; Ply): PlyCP18, PlyCP10, PlyCP33, PlyCP41, and PlyCP26F. The resulting fifteen chimeric proteins were more thermostable than the native
C. perfringens
endolysins, and killed swine and poultry disease-associated strains of
C. perfringens
.
...
PMID:Thermophile Lytic Enzyme Fusion Proteins that Target
Clostridium perfringens
. 3171 57